Iambic Therapeutics, Inc. IAM

IPO NASDAQ
IPO Score
IPO Date
Oct 14, 2026
Recommendation
Dividend Power Score
Day's Range
$13.60$16.50
Latest Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)

06/30/2026 03/31/2026
Total Cash And Short-Term Investments 207.88M 207.88M
Total Receivables 11.61M 11.61M
Inventory -- --
Prepaid Expenses 3.91M 3.91M
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 223.40M 223.40M

Total Current Assets 223.40M 223.40M
Net Property, Plant & Equipment 11.13M 11.13M
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 2.67M 2.67M
Total Assets 237.20M 237.20M

Total Accounts Payable 4.68M 4.68M
Total Accrued Expenses 10.70M 10.70M
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 824.00K 824.00K
Total Finance Division Other Current Liabilities 32.43M 32.43M
Total Other Current Liabilities 32.43M 32.43M
Total Current Liabilities 48.64M 48.64M

Total Current Liabilities 48.64M 48.64M
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases 4.40M 4.40M
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 22.68M 22.68M
Total Liabilities 75.72M 75.72M

Common Stock & APIC 12.70M 12.70M
Retained Earnings -245.30M -245.30M
Treasury Stock & Other 35.00K 35.00K
Total Common Equity -232.56M -232.56M

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 394.04M 394.04M
Preferred Stock, Others -- --
Total Preferred Equity 394.04M 394.04M

Total Common Equity -232.56M -232.56M
Total Preferred Equity 394.04M 394.04M
Total Minority Interest -- --
Total Equity 161.48M 161.48M